St. Francis Cancer Center | St. Francis Cancer Center | Merck MK-3475-177
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1493
clinical-trial-template-default,single,single-clinical-trial,postid-1493,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.7,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

Merck MK-3475-177

A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repaire Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177). >Read More

« Available Clinical Trials